Jan Nielsen joins us as a Senior Principal, bringing over 20 years of experience as a Registered Nurse, Certified Nephrology Nurse and a strong background in clinical, critical care, specialized care and hospital management, incorporating Managed Care, Fee-for-Service, For-Profit, Non-Profit and Start-Ups. She excels at increasing business growth by identifying and pursuing new healthcare markets. Jan […]Read Full Article
Welcome to the Blue Fin Group Information Library. Our consultants regularly publish white papers, case studies and articles, lead workshops, deliver speaking engagements, and share opinions on topics of interest to decision makers in the healthcare industry.
You don’t become an industry leader without having alot to say—click on the video vignettes below to hear our expert’s perspectives on a range of topics.
Blue Fin Group is often sought out as an expert commentator by industry publications — featuring our latest thinking and timely insights on the issues that matter most to the healthcare industry.
Blue Fin Group keeps a lens trained on many facets of the healthcare industry, and our white papers focus on singular topics that are relevant and timely. Known for our out-of-the-box thinking, these insights provide a deeper dive or different viewpoint from what others in the industry provide.
Case studies that show the transformation from challenge to solution. Each one details the existing situation, Blue Fin Group’s unique approach, the solution deployed, and the results achieved on behalf of the client. At Blue Fin Group, we deliver Deep Knowledge. Powerful Results.
Deep knowledge, unique insights and powerful perspectives focused on the healthcare industry, provided by Blue Fin Group associates.
Blue Fin Group, a management and technology consulting firm focused on the pharmaceutical, biotechnology and healthcare industries, is pleased to announce the addition of Michael Turner as Partner. Michael is a strategic partner who brings over 20 years of experience in pharmaceutical strategy and is expected to expand Blue Fin Group’s robust portfolio of offerings, […]Read Full Article
One of my earliest lessons as a Pharmacist was bestowed within my first week of training; always begin with the end in mind. It’s a lesson that transcends work, family, and hobby and is immediately applicable to the common situations of life. As we evaluate our Health Care Ecosystem, it’s painfully apparent that disconnects and […]Read Full Article
John Cervione, Managing Partner, Blue Fin Group, is leading a panel to “Establish Partnerships with IDNs to Streamline Care Coordination” at the World Congress event on July 24 and 25, also attended by Jennifer Hamilton, Partner, Blue Fin Group. Inherent challenges in the commercialization of a specialty product can seem daunting to manufacturer organizations. And […]Read Full Article
Raise your hand if you are reading this blog post while also doing another task. Raise both hands if that other task is “participating” in a meeting, either in-person or virtually. If you raised both hands, you are exactly the person that I want to reach. But put your hands down first, because the truth […]Read Full Article
How can Artificial Intelligence (AI) revolutionize the use of health care data? This is the question in my mind while I’m at the O’Reilly AI conference this week in NYC. AI, really machine learning, is core to the most successful companies like Facebook, Google, Amazon, Netflix, etc. It leverages rich customer data to create highly […]Read Full Article
Wow – 13 years..it seems like just yesterday I attended my first ASCO (American Society of Clinical Oncology) as a brand manager of a new and exciting NSCLC treatment. Months of committee meetings and planning had led to this day and I entered the conference hall in awe – plenary podiums, oral abstracts and poster […]Read Full Article
Blue Fin Group is excited to add our voices to the conversation around Specialty Pharmacy—comment on this blog post to tell us what you think the hot topics will be at the Asembia Summit.Read Full Article